Phase I–II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor-associated carbohydrate antigen Globo H, in patients with advanced solid tumors

Abstract

High-Efficiency Homogeneous ADC Platform by Endoglycosidase Sz Provides Insights into Its Transglycosylation Mechanism

Poster

Positive associations of active immune therapy OBI-833/OBI-821 induced immune responses with clinical outcomes in patients with non-small cell lung cancer

Abstract

Novel TROP2-targeted CAR T cells with high specificity and sustained efficacy for solid tumors in animal models

Abstract

Potential role and prognostic value of Globo-H in lung cancer

Abstract

Clinical Characteristics and Mechanistic links of Tumor and Exosomal Globo H in Patients with Cholangiocarcinoma

Poster

Structure-Based High-Efficiency Homogeneous Antibody Platform by Endoglycosidase Sz Provides Insights into Its Transglycosylation Mechanism

OBI-992, a novel TROP2 targeting antibody-drug conjugate, displayed excellent antitumor efficacy in various animal models

Poster

OBI-992, a novel TROP2 targeting antibody drug conjugate demonstrates superior in vivo PK/PD properties and a favorable safety profile

Poster

In vitro characterization of a novel TROP2-targeting antibody-drug conjugate OBI-992

Poster